Michael S. Marks, PhD
Professor of Pathology and Laboratory Medicine
Professor of Physiology
University of Pennsylvania Perelman School of Medicine
Contact InformationChildren's Hospital of Philadelphia Research Institute
816G Abramson Research Center
3615 Civic Center Blvd.
Philadelphia, PA 19104
Office: (215) 590-3664
Immunobiology and Experimental Pathology
Regulation and diseases of intracellular protein transport and organelle biogenesis.
Regulation of the formation of functional amyloid in organelle biogenesis.
Regulation of antigen processing and toll-like receptor signaling by endosomal trafficking pathways.
Biology of platelet granules.
Key words: Melanosome, lysosome, melanoma, intracellular protein transport, vesicles, secretory lysosomes, Hermansky Pudlak syndrome, amyloid, protein sorting, platelets, hemostasis, dense granules, alpha granules, antigen processing, major histocompatibility complex molecules, toll-like receptors.
Description of Research
Eukaryotic cells are compartmentalized into distinct membrane-bound organelles and vesicular structures, each with its own characteristic function and set of protein constituents. Work in my laboratory is focused on understanding how integral membrane protein complexes are assembled and sorted to the appropriate compartments within the late secretory and endocytic pathways, how sorting and assembly contribute to the biogenesis of specific organelles in several cell types, how these processes impact biological function in the pigmentary, blood clotting, and immune systems, and how they are thwarted by generally rare genetic diseases.
Our primary focus over the past 18 years has been on melanosomes of pigmented cells. Melanosomes are unique lysosome-related organelles present only in cells that make melanin, the major synthesized pigment in mammals. Genetic defects in melanosome constituents or in their delivery to nascent melanosomes result in ocular or oculocutaneous albinism, characterized by lack of pigmentation in the eyes and or skin and concomitant visual impairment and susceptibility to skin and ocular cancers. Melanosomes are among a number of tissue-specific lysosome-related organelles that are malformed and dysfunctional in a group of rare heritable disorders, including Hermansky-Pudlak and Chediak-Higashi syndromes, and pigment cell-specific proteins that localize to melanosomes are targets for the immune system in patients with melanoma. In an effort to understand the molecular basis of these diseases, we are dissecting the molecular mechanisms that regulate how different stage melanosomes are formed and integrated with the endosomal pathway. We use biochemical, morphological, and genetic approaches to follow the fates of melanosome-specific and ubiquitous endosomal and lysosomal proteins within pigment cells from normal individuals or mice and disease models. Using these approaches, we are (1) outlining protein transport pathways that lead to the formation of these unusual organelles, (2) dissecting biochemical pathways that lead to their morphogenesis, and (3) defining how these processes are subverted by genetic disease. Current efforts focus on how factors that are deficient in patients and mouse models of the genetic disease, Hermansky-Pudlak syndrome, impact melanosome biogenesis. We are particularly interested in how these factors contribute to the formation and dynamics of tubular connections between endosomes and maturing melanosomes that facilitate cargo transport, as well as the formation of retrograde membrane carriers that retrieve unneeded proteins from melanosomes.
Because genetic diseases like Hermansky-Pudlak syndrome affect multiple organ systems, we study how similar sorting processes involved in melanosome biogenesis influence other organelles in different cell types. The first involves lysosome-related organelles in platelets called dense granules and alpha granules. When platelets are activated at sites of blood vessel damage, the contents of these granules are released, leading to optimal blood clot formation and platelet activation. Like melanosomes, dense granules are malformed in Hermansky-Pudlak syndrome, and in collaboration with the Poncz, Stalker and French laboratories at CHOP and Penn we are studying how dense granule contents are delivered within platelets and their precursors (megakaryocytes). Studies in collaboration with the Poncz and French labs also address the contents and secretion of alpha granules and their disruption in human bleeding disorders.
The second cellular system is the dendritic cell, a master regulator of T cell-mediated immunity. Patients with Hermansky-Pudlak syndrome type 2 have recurrent bacterial infections, and we have found that this is at least in part due to defects in the way that dendritic cells sense bacterial infection. Normally, ingested bacteria trigger signaling by innate immune receptors present on the membrane enclosing the bacteria (the phagosome); this signaling is defective in dendritic cells from a mouse model of the disease due to impaired recruitment of the receptors and their signaling platforms. Ongoing studies aim to dissect how phagosome membrane dynamics normally lead to signaling and how this is altered in disease states.
Finally, melanosome precursors in pigment cells harbor intrernal fibrils upon which melanins deposit in later stages. The main component of these fibrils is a pigment cell-specific protein, PMEL. Fibrils formed by PMEL in vitro display features common with amyloid formed in disease states such as Alzheimer and Parkinson diseases. By dissecting how PMEL forms amyloid under physiological conditions, we hope to determine how the formation of "good" and "bad" amyloid differs and thus how the formation of "bad" amyloid might be controlled.
Rotation Projects for 2015-2016
1. Define metal import defects in melanocytes from mouse models of Hermansky-Pudlak syndrome types 7-9.
2. Assess the role of Sec1/Munc18 family members in regulating melanosome biogenesis.
3. Assess how the coat protein, AP-3, cooperates with BLOC-1 to facilitate SNARE trafficking to melanosomes, and how defects in AP-3 influence autophagy in melanocytes.
4. Assess phosphoinositide distribution during phagosome maturation in dendritic cells.
5. Test for anterograde and retrograde trafficking defects in dendritic cells and macrophages from Hermansky-Pudlak syndrome model mice.
Adriana Mantegazza - Senior Scientist
Megan Dennis - Post-doctoral fellow
Jialing Bao - Post-doctoral fellow
Hayley Hanby - BGS Graduate Student (CAMB)
Dawn Harper - Research Associate
Emily Stennett - Undergraduate researcher
Tyler Ling - Undergraduate researcher
Biochemistry and Molecular Biophysics
Cell and Molecular Biology
B.S. (Biological Sciences), Cornell University, 1982
Ph.D. (Immunology/Microbiology), Duke University Durham, NC, 1989
IRTA Fellow (1989-1990) and Staff Fellow (1990-1992), Laboratory of Developmental and Molecular Immunity and Laboratory of Molecular Growth Regulation, NICHD, NIH, Bethesda, MD. Mentor: Dr. Keiko Ozato, 1989-1992
NRSA Fellow (1992-1993) and IRTA Fellow (1993-1995), Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD. Mentor: Dr. Juan Bonifacino, 1992-1995
Awards and Honors
National Science Foundation pre-doctoral fellowship, 1983-1986
Duke Univ. merit scholarship, 1983-1987
NRSA post-doctoral fellowship, 1992-1993
NIH Fellows Award for Research Excellence, 1995-1995
Aaron B. Lerner Lectureship/ Pan-American Society for Pigment Cell Research, 2009
Fellow, American Association for the Advancement of Science, 2016
Memberships and Professional Organizations
American Assoc. of Immunologists, 1990 - Present
American Society for Cell Biology, 1994 - Present
American Assoc. for the Advancement of Science, 1994 - Present
The Netherlands Organisation for Health Research and Development (ZonMw), 2003 - 2003
Earth and Life Sciences Council, MEERVOUD program, The Netherlands, 2003 - 2003
Whitehead Fellowships for Junior Faculty in Biomedical or Biological Sciences, New York University, 2003 - 2003
ZAR1 AAA-G J1 Scientific Review Group, NIAMS, National Insitutes of Health, 2003 - 2003
National Science Foundation, 2003 - 2003
R21 High Risk RFA Scientific Review Group, NIAMS, National Institutes of Health, 2004 - 2004
Swiss National Science Foundation, 2004 - 2004
Dutch Cancer Society, The Netherlands, 2004 - 2004
AMS 2007-01 Scientific Review Group, NIAMS, National Institutes of Health, 2006 - 2006
Pan-American Society for Pigment Cell Research, 2008 - 2012
American Society for Biochemistry and Molecular Biology, 2008 - 2012
ZAR1 EHB-D M1 (Small Research Grants) Scientific Review Group, NIAMS, National Institutes of Health, 2008 - 2008
Medical Research Council, UK, 2009 - 2009
Board of Scientific Counselors Review and Evaluation of Intramural Programs, NIDCR, National Institutes of Health, 2010 - 2010
ACTS Scientific Review Group, National Institutes of Health, 2011 - 2011
ZRG1 MDCN B91 Scientific Review Group, National Institutes of Health, 2012 - 2012
Netherlands Organisation for Scientific Research (NWO), 2013 - 2013
British Biomedical Science Research Council, 2013 - 2013
ACTS Scientific Review Group, National Institutes of Health, 2013 - 2015
European Society for Pigment Cell Research, 2013 - present
Board of Scientific Counselors Review and Evaluation of Intramural Programs, NIDCR, National Institutes of Health, 2013 - 2013
Membrane Biology and Protein Processing Study Section, NIH, 2015 - Present
Medical Research Council, UK, 2015 - 2015
BLOC-1 and BLOC-3 regulate VAMP7 cycling to and from melanosomes via distinct tubular transport carriers
Dennis MK, Delevoye C, Acosta-Ruiz A, Hurbain I, Romao M, Hesketh GG, Goff PS, Sviderskaya EV,Bennett DC, Luzio JP, Galli T, Owen DJ, Raposo G, Marks MS, J. Cell Biol. 214(3): 293-308, 2016, PMID:27482051
The Kringle-Like Domain facilitates post-endoplasmic reticulum changes to PMEL oligomerization and disulfide bond configuration and promotes amyloid formation
Ho T, Watt B, Spruce LA, Seeholzer SH and Marks MS, J. Biol. Chem. 291(7): 3595-3612, 2016, PMID:26694611
Delevoye C, Heiligenstein X, Ripoll L, Gilles-Marsens F, Dennis MK, Linares RA, Derman L, Gokhale A, Morel E, Faundez V, Marks MS and Raposo G, Curr. Biol. 26(1): 1-13, 2016, PMID:26725201
*Dennis MK, *Mantegazza AR, Snir OL, Tenza D, Acosta-Ruiz A, Delevoye C, Zorger R, Sitaram A, de Jesus-Rojas W, Ravichandran K, Rux J, Sviderskaya EV, Bennett DC, Raposo G, Marks MS** and **Setty SRG, J. Cell Biol. 209(4): 563-577, 2015, PMID:26008744
Defective release of alpha-granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models
Meng R, Wu J, Harper DC, Wang Y, Kowalska MA, Abrams CS, Brass LF, Poncz M, Stalker TJ, and Marks MS, Blood 125(10): 1623-1632, 2015, PMID:25477496
Bellono N, Escobar IE, Lefkovith AJ, Marks MS and Oancea EV, eLife 3(): e04543, 2014, PMID:25513726
TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation
Mantegazza AR, Zajac AL, Twelvetrees A, Holzbaur EL, Amigorena S and Marks MS, Proc. Natl. Acad. Sci. U.S.A. 111(43): 15508-15513, 2014, PMID:25313083
Delevoye C, Miserey-Lenkei S, Montagnac G, Gilles-Marsens F, Paul-Gilloteaux P, Giordano F, Waharte F, Marks MS, Goud B and Raposo G, Cell Rep. 6(3): 445-454, 2014, PMID:24462287
Marks MS, Heijnen HFG and Raposo G, Curr. Opin. Cell Biol. 25(4): 495-505, 2013, PMID:23726022
Adaptor protein-3 in dendritic cells facilitates phagosomal Toll-like receptor signaling and antigen presentation to CD4+ T cells.
Mantegazza AR, Guttentag SH, El-Benna J, Sasai M, Iwasaki A, Shen H, Laufer TM and Marks MS, Immunity 36(5): 782-794, 2012